While earlier studies have explored the ability of a small subset of IFNα subtypes to augment NK cell cytotoxicity in vitro (16), there has been no systematic analysis to determine whether a particular IFN-I subtype confers enhanced NK cell responses against leukaemia. This evidence concerns the gene IFNA1 and leukemia.